孟加拉国研究表明，伊维菌素组合可以治疗COVID-19
孟加拉国内科医生与外科学学院杂志7月号包括：
“用伊维菌素和强力霉素联合治疗的100例COVID-19阳性患者的病例系列。”
鉴于研究显示伊维菌素
可以限制SARS-CoV-2进入试管，研究人员着手观察这是否可以转化为有效药物。
该研究对100名患者进行了研究，结果如下：
在接受药物加抗生素治疗的8至84岁患者中，在开始用药的第4天和第18天进行了重新测试。
“所有患者测试均为阴性，其症状在72小时内得到改善。 没有明显的副作用。”
The paper concludes that
“Combination of Ivermectin and doxycycline was found to be very effective in viral clearance in mild and moderately sick COVID-19 patients.
Medical societies and institutions
should undertake larger multi center studies to validate and recommend this combination therapy to include in national guidelines.”
https://www.trialsitenews.com/bangladesh-study-suggests-that-ivermectin-combo-can-treat-covid-19/
Comparison of Viral Clearance between Ivermectin with Doxycycline and Hydroxychloroquine with Azithromycin in COVID-19 PatientsMA Rahman, SA Iqbal, MA Islam, MK Niaz, T Hussain, TH Siddiquee | Welcome to BCPS Journal